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Outline
Why do we care about aggregation in 
biopharmaceuticals?
Review some basic facts about aggregate sizes and 
types
Mechanisms for aggregation
Utility of sedimentation velocity for analysis of  
aggregation
Introduction to classical light scattering used on-
line with SEC (SEC-MALLS)
A few words about field-flow fractionation (FFF)
Protein aggregates: What is all the 
fuss about?
Aggregates (or partially assembled states for 
products like VLPs that are supposed to be 
associated) are often a major degradation product
Hence they often are a major factor limiting shelf life
Aggregates or other undesired assembly states in 
the product may affect its:
1. manufacturability 
clogged columns or diafiltration membranes
2. bioactivity (potency)
3. serum half-life or absorption rate
4. immunogenicity
Size matters…
The word “aggregate” covers a wide spectrum 
of types and sizes of associated states
1. rapidly-reversible non-covalent small oligomers 
(dimer, trimer, tetramer…)
2. irreversible non-covalent oligomers
3. covalent oligomers (e.g. disulfides)
4. “large” aggregates (> 10-mer)
could be reversible if non-covalent
5. “very large” aggregates (diameter ~50 nm to 3 
μm)






Reversible vs. irreversible aggregates
Whether aggregates are “irreversible” or 
“reversible” depends on the context
solvent components
salts, sugars, other excipients
organic modifiers (alcohols, acetonitrile)
pH
temperature
how long you wait
Aggregates have a spectrum of lifetimes
rates of non-covalent association and dissociation (half-
times) can vary from milliseconds to days
many common analytical methods will detect only the 
longer-lived species
metastable oligomers with dissociation rates of hours to 
days occur fairly frequently
likely true for large structures like VLPs or KLH
not uncommon for small proteins, monoclonal antibodies
it may take hours to days for the size distribution to re-
equilibrate after a change in concentration, solvent 
conditions or temperature
Aggregation mechanisms (1): reversible 































protein, or a 
contaminant)
Addition of protein 
monomers onto 
surface of nucleus 


























1. Any sample may contain aggregates with a wide 
range of sizes, types, and lifetimes
2. Any one analysis method may not detect all the 
aggregate sizes or types that are present
3. The measurement itself may perturb the aggregate 
distribution that was initially present
The measurement itself may create or destroy 
aggregates
dissociation or loss of aggregates can be caused by: SEC SV FFF
dilution +++ + ++
change of solvent conditions +++ - ++
adsorption to surfaces +++ + ++
physical filtration (e.g. column frit) +++ - -
physical disruption (e.g. shear forces) ++ - -
creation of new aggregates can be caused by:
change of solvent conditions +++ - ++
surface or shear-induced denaturation ++ - +
concentration on surface - - ++
Regulatory concerns about analytical methods 
for aggregation/assembly
Adverse events and other problems with certain protein 
therapeutics have heightened awareness of the limitations 
of common analytical methods
For protein therapeutics they will now nearly always ask for 
cross-validation of sizing protocols by orthogonal methods
May see some spill-over over these concerns to vaccine 
products





flow mode classical scattering used after SEC (SEC-
MALLS)
batch mode dynamic light scattering (DLS)
batch mode classical scattering
field-flow fractionation (FFF)
usually used with MALLS to measure true MW
← has been validated
← has been validated
Time won’t permit talking about dynamic light scattering 
or in detail about other methods today, but…
Background and examples for DLS, SV, and SEC-MALLS 
can be found on the APL web site, www.ap-lab.com
Many articles, talks, and posters on aggregation and 
comparability studies can be downloaded from our 
‘Further Reading’ page
Sedimentation velocity
The fundamentals of sedimentation velocity





























The sedimentation coefficient 
is determined from the 
boundary motion over time. It 
depends on both molecular 





















High resolution analysis of a highly stressed antibody 
sample resolves 6 aggregate peaks plus 2 fragments

























































































This interferon-β sample is 13.7% non-covalent 
aggregate; by the standard SEC method it would 
be pure monomer


























Detection of viral aggregates and empty capsids in an 
adenoviral gene therapy vector















sedimentation coefficient, s20,w (Svedbergs)














Berkowitz, S. A. and Philo, J. S. (2007). Monitoring the homogeneity of adenovirus preparations (a gene therapy delivery 
system) using analytical ultracentrifugation.  Anal. Biochem. 362, 16-37.
“good enough” vaccine;
Phil Minor
KLH size distribution in fresh, unpurified hemolymph from 
a single animal (monitored at 340 nm so only KLH is seen)

















































Size distributions for commercial KLH preparations differ 
from each other and only partially resemble that in vivo






 commercial KLH 1


































Multi-angle classical laser light scattering 
used on-line with SEC (SEC-MALLS)
Typical setup for size-exclusion chromatography with on-









Getting molecular mass from static light scattering: the 
basic idea
from theory, the amount of light scattered by the 
protein at some angle will be proportional to the product 
c × M × (dn/dc)2
dn/dc is the “refractive increment” (difference in 
refractive index relative to solvent); its value is nearly 
identical for all non-conjugated proteins
if we measure c simultaneously with a UV or RI 
detector, then the ratio of the scattering to 
concentration signals will be proportional to M
masses obtained this way are absolute, and 
independent of elution position
An example for an Fc-fusion protein: the aggregate signals are 
much stronger in 90° scattering than in the RI chromatogram
scattering intensity RI
elution volume (ml)














Identifying minor components in a heat-stressed 
monoclonal antibody
time (min)






























































































This highly stressed sample of a vaccine antigen showed high 
levels of an SEC peak eluting near the position expected for a 
dimer
volume (ml)


















However SEC-MALLS immediately shows this alleged aggregate 
is actually an altered form of monomer!
Field-flow fractionation (FFF)
Principles of cross-flow FFF
figure courtesy Wyatt Technology
FFF of an acid-exposed monoclonal antibody 
[courtesy D. Ejima (Ajinomoto) and K. Tsumoto (U. Tokyo)]
FFF using 0.1 M 
citrate, pH 2.9
FFF after titration 
to neutral pH, elute 
using 0.1 M 
phosphate, pH 6.8
Advantages & drawbacks of FFF
main advantages
1. much less surface area for absorption of sticky 
aggregates than SEC columns
2. can separate a much wider range of sizes than SEC
drawbacks
1. some proteins stick to all the available membranes
2. many parameters need to be optimized during 
method development
3. dilution may dissociate reversible aggregates
Summary
1. Aggregation is a complex phenomenon!
2. No single analytical method is optimal for all types and 
sizes of aggregates
3. Alternative sizing methods tend to be complex, require 
highly skilled personnel, and are not generally usable for 
QC
4. Our ability to characterize aggregates or improperly 
associated species unfortunately far exceeds our 
knowledge of how such species affect product safety or 
efficacy
